Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients

Analyses of gene expression in cells affected by neurodegenerative disease can provide important insights into disease mechanisms and relevant stress response pathways. Major symptoms in Parkinson’s disease (PD) are caused by the degeneration of midbrain dopamine (mDA) neurons within the substantia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Katarína Tiklová, Linda Gillberg, Nikolaos Volakakis, Hilda Lundén-Miguel, Lina Dahl, Geidy E. Serrano, Charles H. Adler, Thomas G. Beach, Thomas Perlmann
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/2688c8e2113b4db987bfcd1c61b338d9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2688c8e2113b4db987bfcd1c61b338d9
record_format dspace
spelling oai:doaj.org-article:2688c8e2113b4db987bfcd1c61b338d92021-11-11T15:28:24ZDisease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients1662-509910.3389/fnmol.2021.763777https://doaj.org/article/2688c8e2113b4db987bfcd1c61b338d92021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnmol.2021.763777/fullhttps://doaj.org/toc/1662-5099Analyses of gene expression in cells affected by neurodegenerative disease can provide important insights into disease mechanisms and relevant stress response pathways. Major symptoms in Parkinson’s disease (PD) are caused by the degeneration of midbrain dopamine (mDA) neurons within the substantia nigra. Here we isolated neuromelanin-positive dopamine neurons by laser capture microdissection from post-mortem human substantia nigra samples recovered at both early and advanced stages of PD. Neuromelanin-positive cells were also isolated from individuals with incidental Lewy body disease (ILBD) and from aged-matched controls. Isolated mDA neurons were subjected to genome-wide gene expression analysis by mRNA sequencing. The analysis identified hundreds of dysregulated genes in PD. Results showed that mostly non-overlapping genes were differentially expressed in ILBD, subjects who were early after diagnosis (less than five years) and those autopsied at more advanced stages of disease (over five years since diagnosis). The identity of differentially expressed genes suggested that more resilient, stably surviving DA neurons were enriched in samples from advanced stages of disease, either as a consequence of positive selection of a less vulnerable long-term surviving mDA neuron subtype or due to up-regulation of neuroprotective gene products.Katarína TiklováKatarína TiklováLinda GillbergLinda GillbergNikolaos VolakakisHilda Lundén-MiguelLina DahlGeidy E. SerranoCharles H. AdlerThomas G. BeachThomas PerlmannFrontiers Media S.A.articleParkinson’s diseasegene expressionRNA sequencingdisease durationneurodegenerative diseasecell deathNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Molecular Neuroscience, Vol 14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Parkinson’s disease
gene expression
RNA sequencing
disease duration
neurodegenerative disease
cell death
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle Parkinson’s disease
gene expression
RNA sequencing
disease duration
neurodegenerative disease
cell death
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Katarína Tiklová
Katarína Tiklová
Linda Gillberg
Linda Gillberg
Nikolaos Volakakis
Hilda Lundén-Miguel
Lina Dahl
Geidy E. Serrano
Charles H. Adler
Thomas G. Beach
Thomas Perlmann
Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients
description Analyses of gene expression in cells affected by neurodegenerative disease can provide important insights into disease mechanisms and relevant stress response pathways. Major symptoms in Parkinson’s disease (PD) are caused by the degeneration of midbrain dopamine (mDA) neurons within the substantia nigra. Here we isolated neuromelanin-positive dopamine neurons by laser capture microdissection from post-mortem human substantia nigra samples recovered at both early and advanced stages of PD. Neuromelanin-positive cells were also isolated from individuals with incidental Lewy body disease (ILBD) and from aged-matched controls. Isolated mDA neurons were subjected to genome-wide gene expression analysis by mRNA sequencing. The analysis identified hundreds of dysregulated genes in PD. Results showed that mostly non-overlapping genes were differentially expressed in ILBD, subjects who were early after diagnosis (less than five years) and those autopsied at more advanced stages of disease (over five years since diagnosis). The identity of differentially expressed genes suggested that more resilient, stably surviving DA neurons were enriched in samples from advanced stages of disease, either as a consequence of positive selection of a less vulnerable long-term surviving mDA neuron subtype or due to up-regulation of neuroprotective gene products.
format article
author Katarína Tiklová
Katarína Tiklová
Linda Gillberg
Linda Gillberg
Nikolaos Volakakis
Hilda Lundén-Miguel
Lina Dahl
Geidy E. Serrano
Charles H. Adler
Thomas G. Beach
Thomas Perlmann
author_facet Katarína Tiklová
Katarína Tiklová
Linda Gillberg
Linda Gillberg
Nikolaos Volakakis
Hilda Lundén-Miguel
Lina Dahl
Geidy E. Serrano
Charles H. Adler
Thomas G. Beach
Thomas Perlmann
author_sort Katarína Tiklová
title Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients
title_short Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients
title_full Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients
title_fullStr Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients
title_full_unstemmed Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients
title_sort disease duration influences gene expression in neuromelanin-positive cells from parkinson’s disease patients
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/2688c8e2113b4db987bfcd1c61b338d9
work_keys_str_mv AT katarinatiklova diseasedurationinfluencesgeneexpressioninneuromelaninpositivecellsfromparkinsonsdiseasepatients
AT katarinatiklova diseasedurationinfluencesgeneexpressioninneuromelaninpositivecellsfromparkinsonsdiseasepatients
AT lindagillberg diseasedurationinfluencesgeneexpressioninneuromelaninpositivecellsfromparkinsonsdiseasepatients
AT lindagillberg diseasedurationinfluencesgeneexpressioninneuromelaninpositivecellsfromparkinsonsdiseasepatients
AT nikolaosvolakakis diseasedurationinfluencesgeneexpressioninneuromelaninpositivecellsfromparkinsonsdiseasepatients
AT hildalundenmiguel diseasedurationinfluencesgeneexpressioninneuromelaninpositivecellsfromparkinsonsdiseasepatients
AT linadahl diseasedurationinfluencesgeneexpressioninneuromelaninpositivecellsfromparkinsonsdiseasepatients
AT geidyeserrano diseasedurationinfluencesgeneexpressioninneuromelaninpositivecellsfromparkinsonsdiseasepatients
AT charleshadler diseasedurationinfluencesgeneexpressioninneuromelaninpositivecellsfromparkinsonsdiseasepatients
AT thomasgbeach diseasedurationinfluencesgeneexpressioninneuromelaninpositivecellsfromparkinsonsdiseasepatients
AT thomasperlmann diseasedurationinfluencesgeneexpressioninneuromelaninpositivecellsfromparkinsonsdiseasepatients
_version_ 1718435228938141696